Geode Capital Management »

Keros Therapeutics shares owned by Geode Capital Management

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Geode Capital Management from 13F filings

Historical chart of Geode Capital Management investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by Geode Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by Geode Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $40M 596k 66.21
2023-09-30 $16M 486k 31.88
2023-06-30 $17M 421k 40.18
2023-03-31 $16M 368k 42.70
2022-12-31 $17M 350k 48.02
2022-09-30 $12M 316k 37.62
2022-06-30 $7.6M 275k 27.63
2022-03-31 $15M 275k 54.38
2021-12-31 $15M 256k 58.51
2021-09-30 $8.4M 213k 39.56
2021-06-30 $9.4M 221k 42.47
2021-03-31 $11M 174k 61.54
2020-12-31 $11M 158k 70.54
2020-09-30 $4.2M 110k 38.56
2020-06-30 $4.0M 107k 37.51